Condition
Clinical Infection
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05796362Phase 1Completed
A Single-Dose, Three-Way, Three-Sequence, Crossover BA Study of Azithromycin Oleogel
NCT05268419Phase 3CompletedPrimary
Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study)
NCT03856138CompletedPrimary
Effect of Gut Microbiota and Fecal Inflammatory Marker on Childhood Gastroenteritis
NCT02020213Phase 4WithdrawnPrimary
Posaconazole as Salvage Therapy for Aspergillus Pulmonary Infection.
Showing all 4 trials